Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 296

1.

Prevalence, incidence and predictors of anal high-risk HPV infections and cytological abnormalities in HIV-infected individuals.

Borghetti A, Cattani P, Maria G, D'Onghia S, Santangelo R, Marchetti S, Farina S, Cauda R, De Luca A, Di Giambenedetto S.

J Infect. 2014 Aug 15. pii: S0163-4453(14)00241-2. doi: 10.1016/j.jinf.2014.07.025. [Epub ahead of print]

PMID:
25135229
[PubMed - as supplied by publisher]
2.

Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study.

Giannella M, Trecarichi EM, De Rosa FG, Del Bono V, Bassetti M, Lewis RE, Losito AR, Corcione S, Saffioti C, Bartoletti M, Maiuro G, Cardellino CS, Tedeschi S, Cauda R, Viscoli C, Viale P, Tumbarello M.

Clin Microbiol Infect. 2014 Jul 1. doi: 10.1111/1469-0691.12747. [Epub ahead of print]

PMID:
24980276
[PubMed - as supplied by publisher]
3.

Gene Xpert MTB/RIF assay confirms its value in the first multicentre, randomised, controlled trial conducted in primary-care settings in Africa.

Cauda R.

Pathog Glob Health. 2014 Apr;108(3):127. doi: 10.1179/2047772414Z.000000000200. No abstract available.

PMID:
24766336
[PubMed - in process]
4.

Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae.

Tumbarello M, Trecarichi EM, Tumietto F, Del Bono V, De Rosa FG, Bassetti M, Losito AR, Tedeschi S, Saffioti C, Corcione S, Giannella M, Raffaelli F, Pagani N, Bartoletti M, Spanu T, Marchese A, Cauda R, Viscoli C, Viale P.

Antimicrob Agents Chemother. 2014 Jun;58(6):3514-20. doi: 10.1128/AAC.02373-13. Epub 2014 Apr 14.

PMID:
24733460
[PubMed - in process]
5.

Evaluation of efficacy, pharmacokinetics and tolerability of peptidomimetic aspartic proteinase inhibitors as cream formulation in experimental vaginal candidiasis.

De Bernardis F, Arancia S, Tringali G, Greco MC, Ragazzoni E, Calugi C, Trabocchi A, Sandini S, Graziani S, Cauda R, Cassone A, Guarna A, Navarra P.

J Pharm Pharmacol. 2014 Aug;66(8):1094-101. doi: 10.1111/jphp.12240. Epub 2014 Mar 13.

PMID:
24628362
[PubMed - in process]
6.

Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data.

Dello Russo C, Lisi L, Fabbiani M, Gagliardi D, Fanti I, Di Giambenedetto S, Cauda R, Navarra P.

Pharmacogenomics. 2014 Feb;15(3):319-27. doi: 10.2217/pgs.13.242.

PMID:
24533711
[PubMed - in process]
Free Article
7.

Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis.

Gagliardini R, Fabbiani M, Fortuna S, Visconti E, Navarra P, Cauda R, Colafigli M, De Luca A, Trecarichi EM, Di Giambenedetto S.

Infection. 2014 Aug;42(4):775-8. doi: 10.1007/s15010-014-0599-z. Epub 2014 Feb 15.

PMID:
24531907
[PubMed - in process]
8.

Ophthalmic artery resistance index is increased in HIV-Infected patients and is influenced by protease inhibitors exposure.

Fabbiani M, Grima P, Borghetti A, Colafigli M, D'Avino A, Mondi A, Gagliardini R, De Luca A, Cauda R, Di Giambenedetto S.

J Infect. 2014 May;68(5):500-3. doi: 10.1016/j.jinf.2014.01.012. Epub 2014 Feb 6. No abstract available.

PMID:
24509141
[PubMed - in process]
9.

Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis.

De Angelis G, Cataldo MA, De Waure C, Venturiello S, La Torre G, Cauda R, Carmeli Y, Tacconelli E.

J Antimicrob Chemother. 2014 May;69(5):1185-92. doi: 10.1093/jac/dkt525. Epub 2014 Jan 23.

PMID:
24458513
[PubMed - in process]
10.

Immune response to influenza A(H1N1)v in HIV-infected patients.

Sansonetti P, Sali M, Fabbiani M, Morandi M, Martucci R, Danesh A, Delogu G, Bermejo-Martin JF, Sanguinetti M, Kelvin D, Cauda R, Fadda G, Rubino S.

J Infect Dev Ctries. 2014 Jan 15;8(1):101-9. doi: 10.3855/jidc.3147.

PMID:
24423719
[PubMed - indexed for MEDLINE]
Free Article
11.

Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients.

Fabbiani M, Zaccarelli M, Grima P, Prosperi M, Fanti I, Colafigli M, D'Avino A, Mondi A, Borghetti A, Fantoni M, Cauda R, Di Giambenedetto S.

BMC Infect Dis. 2014 Jan 13;14:26. doi: 10.1186/1471-2334-14-26.

PMID:
24418191
[PubMed - in process]
Free PMC Article
12.

Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study).

Fabbiani M, Mondi A, Colafigli M, D'Ettorre G, Paoletti F, D'Avino A, Ciccarelli N, Sidella L, Murri R, Fortuna S, Vullo V, Cauda R, De Luca A, Di Giambenedetto S.

Scand J Infect Dis. 2014 Jan;46(1):34-45. doi: 10.3109/00365548.2013.840920. Epub 2013 Oct 28.

PMID:
24161018
[PubMed - indexed for MEDLINE]
13.

Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group.

Svicher V, Alteri C, Montano M, Nori A, D'Arrigo R, Andreoni M, Angarano G, Antinori A, Antonelli G, Allice T, Bagnarelli P, Baldanti F, Bertoli A, Borderi M, Boeri E, Bon I, Bruzzone B, Barresi R, Calderisi S, Callegaro AP, Capobianchi MR, Gargiulo F, Castelli F, Cauda R, Ceccherini-Silberstein F, Clementi M, Chirianni A, Colafigli M, D'Arminio Monforte A, De Luca A, Di Biagio A, Di Nicuolo G, Di Perri G, Di Santo F, Fadda G, Galli M, Gennari W, Ghisetti V, Costantini A, Gori A, Gulminetti R, Leoncini F, Maffongelli G, Maggiolo F, Maserati R, Mazzotta F, Meini G, Micheli V, Monno L, Mussini C, Nozza S, Paolucci S, Palù G, Parisi S, Parruti G, Pignataro AR, Quirino T, Re MC, Rizzardini G, Sanguinetti M, Santangelo R, Scaggiante R, Sterrantino G, Turriziani O, Vatteroni ML, Viscoli C, Vullo V, Zazzi M, Lazzarin A, Perno CF.

Infection. 2014 Feb;42(1):61-71. doi: 10.1007/s15010-013-0510-3. Epub 2013 Oct 22.

PMID:
24146352
[PubMed - in process]
Free PMC Article
14.

The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study.

De Luca A, de Gaetano Donati K, Colafigli M, Cozzi-Lepri A, De Curtis A, Gori A, Sighinolfi L, Giacometti A, Capobianchi MR, D'Avino A, Iacoviello L, Cauda R, D'Arminio Monforte A.

BMC Infect Dis. 2013 Sep 3;13:414. doi: 10.1186/1471-2334-13-414.

PMID:
24004495
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Variability of raltegravir plasma levels in the clinical setting.

Fortuna S, Fabbiani M, Digiambenedetto S, Ragazzoni E, Lisi L, Cauda R, Navarra P.

Pharmacology. 2013;92(1-2):43-8. doi: 10.1159/000351851. Epub 2013 Jul 25.

PMID:
23887354
[PubMed - indexed for MEDLINE]
16.

Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients.

Ciccarelli N, Fabbiani M, Grima P, Falasca K, Tana M, Baldonero E, Colafigli M, Silveri MC, Vecchiet J, Cauda R, Di Giambenedetto S.

Infection. 2013 Dec;41(6):1103-9. doi: 10.1007/s15010-013-0503-2. Epub 2013 Jul 10.

PMID:
23839213
[PubMed - indexed for MEDLINE]
17.

HIV-infected patients show impaired cellular immune response to influenza vaccination compared to healthy subjects.

Fabbiani M, Sidella L, Corbi M, Martucci R, Sali M, Colafigli M, Cauda R, Delogu G, Sgambato A, Di Giambenedetto S.

Vaccine. 2013 Jun 19;31(28):2914-8. doi: 10.1016/j.vaccine.2013.04.033. Epub 2013 Apr 24.

PMID:
23623859
[PubMed - indexed for MEDLINE]
18.

Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia.

Ciccarelli N, Fabbiani M, Colafigli M, Trecarichi EM, Silveri MC, Cauda R, Murri R, De Luca A, Di Giambenedetto S.

Antivir Ther. 2013;18(2):153-60. doi: 10.3851/IMP2560. Epub 2013 Mar 13.

PMID:
23486721
[PubMed - indexed for MEDLINE]
19.

Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study).

Di Giambenedetto S, Fabbiani M, Colafigli M, Ciccarelli N, Farina S, Sidella L, D'Avino A, Mondi A, Cingolani A, Tamburrini E, Murri R, Navarra P, Cauda R, De Luca A.

J Antimicrob Chemother. 2013 Jun;68(6):1364-72. doi: 10.1093/jac/dkt007. Epub 2013 Jan 30.

PMID:
23372058
[PubMed - indexed for MEDLINE]
Free Article
20.

Mortality in patients with early- or late-onset candidaemia.

De Rosa FG, Trecarichi EM, Montrucchio C, Losito AR, Raviolo S, Posteraro B, Corcione S, Di Giambenedetto S, Fossati L, Sanguinetti M, Serra R, Cauda R, Di Perri G, Tumbarello M.

J Antimicrob Chemother. 2013 Apr;68(4):927-35. doi: 10.1093/jac/dks480. Epub 2012 Dec 12.

PMID:
23236102
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk